Ask Warren

Genesystem

363250 · KOSDAQ · ₩363250 · 진시스템

₩4,025▼ ₩90 (2.19%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩432M₩329M₩158M₩90M₩69M₩63M₩123M₩803M
Cost of sales₩546M₩306M₩1.6B₩600M₩645M₩35M₩1.3B₩932M
Gross profit−₩113M₩23M−₩1.4B−₩510M−₩576M₩29M−₩1.2B−₩129M
Operating income−₩958M−₩1.6B−₩3B−₩2.3B−₩2.4B−₩2B−₩3.3B−₩2.1B
Net income−₩814M−₩1.6B−₩8.2B−₩2.2B−₩2.4B−₩1.9B−₩3.1B−₩2B
Net income to shareholders−₩811M−₩1.5B−₩5.9B−₩2B−₩2.2B−₩1.8B−₩2.9B−₩1.9B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩18B₩16B₩14B₩24B₩25B₩28B₩30B₩31B
Current assets₩8.1B₩6.2B₩2.7B₩5.6B₩6.3B₩8.2B₩10B₩13B
Cash and equivalents₩4.1B₩4.3B₩1.1B₩2.8B₩3.4B₩5.4B₩5.6B₩7.9B
Total liabilities₩6.1B₩6.2B₩6.6B₩8B₩7.7B₩8.1B₩8B₩7.8B
Current liabilities₩2.2B₩2.4B₩2.5B₩2.5B₩2.4B₩2.5B₩2.5B₩2B
Borrowings₩3.7B₩3.7B₩3.7B₩3.8B₩3.8B₩4B₩4B₩4.3B
Total equity₩12B₩9.4B₩7.7B₩16B₩18B₩20B₩22B₩23B
Shareholders' equity₩12B₩9.6B₩7.9B₩13B₩15B₩18B₩19B₩20B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3B−₩2B−₩1.6B−₩1.6B−₩1.7B−₩2B−₩2B−₩2B
Capital spending₩360M₩53M₩1.5M₩108M₩17M₩93M₩127M₩51M
Free cash flow−₩3.4B−₩2.1B−₩1.6B−₩1.7B−₩1.7B−₩2.1B−₩2.1B−₩2B

Consolidated where available. Amounts in won.

Also known as: Genesystem / 진시스템 / 363250 / KRX:363250

Source: KRX statistical information